Authors: Romano M R.; Montericcio A.; Montalbano C.; Raimondi R.; Allegrini D.; Ricciardelli G.; Angi M.; Pagano L.; Romano V.
Curr Eye Res: April 23, 2020 - Published online
doi: 10.1080/02713683.2020.1752737 Online version
This is a: Publication
Purpose: To provide useful guidelines, targeted at ophthalmology professionals, to minimize COVID-19 infection of both health-care workers and patients.
Methods: In this review we present updated literature merged with our experience from hospitals in Bergamo, the epicenter of the COVID-19 European outbreak.
Results: Non-pharmaceutical interventions, hygienic recommendations and personal protective equipment to contain viral spread as well as a suggested risk assessment for postponement of non-urgent cases should be applied in ophthalmologist activity. A triage for ophthalmic outpatient clinic is mandatory.
Conclusion: Ophthalmology practice should be reorganized in order to face COVID-19.
Alchimia is one of the leading European manufacturers of medical devices for ophthalmic surgery and human tissue banking with the aim of improving the daily routine of the medical personnel and the quality of life of patients.